Propanc Biopharma, Inc. (PPCB) stock
PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30
$1.76−0.12 (-6.38%)
Close on Nov 18, 2026Market cap $1.73MP/E –Yield –
Propanc Biopharma gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Propanc Biopharma
Propanc Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?